# AN NHP EFFICACY STUDY OF BIO 300 FOR MITIGATOR FOR DEARE-INDUCED PNEUMONITIS AND PULMONARY FIBROSIS

> **NIH NIH N01** · HUMANETICS CORPORATION · 2020 · $1,833,338

## Abstract

This contract supports the development of safe and effective MCMs to mitigate and/or treat tissue injuries arising from exposure to ionizing radiation from a radiological or nuclear incident, thereby leading to a reduction in radiation-associated morbidities and mortalities.

## Key facts

- **NIH application ID:** 10131063
- **Project number:** 272201800011C-P00007-9999-1
- **Recipient organization:** HUMANETICS CORPORATION
- **Principal Investigator:** JOHN DYKSTRA
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,833,338
- **Award type:** —
- **Project period:** 2020-04-01 → 2021-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10131063

## Citation

> US National Institutes of Health, RePORTER application 10131063, AN NHP EFFICACY STUDY OF BIO 300 FOR MITIGATOR FOR DEARE-INDUCED PNEUMONITIS AND PULMONARY FIBROSIS (272201800011C-P00007-9999-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10131063. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*